Product Information

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1256 per EA under NDC 31722094205. Its NADAC has been published 385 times since Jul 10, 2019.

FDA first approved this application on Nov 7, 2018. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.1256per EA
DEA Schedule CII

Strength

325; 7.5 mg/1; mg/1

NDC

31722094205

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211487

FDA Approved

11/7/2018

TE Code

AA

On Market Since

8/22/2025

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 385 times since Jul 10, 2019, and over the history we have for it it has risen 19.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1256 per EA
All-time high$0.1630 (Jul 10, 2024)
All-time low$0.0932 (Dec 18, 2019)
52-week high$0.1485
52-week low$0.1256
Median price$0.1335
Average price$0.1325
Largest weekly change+41.5% (Jan 22, 2020)
Weeks tracked385
Tracking sinceJul 10, 2019

Price History

1W

-3.8%

1M

-7.2%

3M

-9.1%

6M

-9.0%

1Y

-15.4%

3Y

-0.8%

5Y

+13.1%

All

+19.6%

Generic Alternatives

The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1256 per EA (NDC 31722094205), effective Nov 18, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has risen 19.6%. It has been tracked across 385 weekly CMS publications since Jul 10, 2019.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

Since Jul 10, 2019, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.0932 (Dec 18, 2019) to a high of $0.1630 (Jul 10, 2024), with a median of $0.1335 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

13 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 31722094205) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.